1. Wuchty S, Almaas E: Evolutionary cores of domain co-occurrence networks. BMC Evol Biol. 2005, 5: 24.
  2. Hogan BL: Bone morphogenetic proteins in development. Curr Opin Genet Dev 1996, 6: 432–438.
  3. Naber HP, Wiercinska E, Pardali E, van Laar T, Nirmala E, Sundqvist A: BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β(3) expression. Cell Oncol (Dordr). In press.
  4. Chen J, Ye L, Xie F, Yang Y, Zhang L, Jiang WG: Expression of bone morphogenetic protein 7 in lung cancer and its biological impact on lung cancer cells. Anticancer Res. 2010, 30: 1113-1120.
  5. Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H: Clinical significance of BMP7 in human colorectal cancer. Ann Surg Oncol. 2008, 15: 1530-1537.
  6. Alarmo EL, Pärssinen J, Ketolainen JM, Savinainen K, Karhu R, Kallioniemi A: BMP7 influences proliferation, migration, and invasion of breast cancer cells. Cancer Lett. 2009, 275: 35-43.
  7. Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K: Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer. 2003, 103: 455-465.
  8. Thériault BL, Shepherd TG, Mujoomdar ML, Nachtigal MW: BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis. 2007, 28: 1153-1162.
  9. Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L: Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology. 2011, 140: 297-309.
  10. Ketolainen JM, Alarmo EL, Tuominen VJ, Kallioniemi A: Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4. Breast Cancer Res Treat. 2010, 124: 377-386
  11. Su D, Peng X, Zhu S, Huang Y, Dong Z, Zhang Y: Role of p38 MAPK pathway in BMP4-mediated Smad-dependent premature senescence in lung cancer cells. Biochem J. 2011, 433: 333-343.
  12. Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS: Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol. 2009, 218: 520-529.
  13. Wei S, Dunn TA, Isaacs WB, De Marzo AM, Luo J: GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus. Prostate. 2008, 68: 1387-1395.
  14. Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S: The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res. 2010, 8: 529-538.
  15. Zhang Y, Wang S, Li D, Zhang J, Gu D, Zhu Y, He F: A systems biology-based classifier for hepatocellular carcinoma diagnosis. 2011, 6: e22426
  16. Kieback DG, Press MF, Atkinson EN, Edwards GL, Möbus VJ, Runnebaum IB, Kreienberg R, Jones LA: Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL). Anticancer Res. 1993, 13: 2489-2496.
  17. Ludbrook J: Analysis of 2 x 2 tables of frequencies: matching test to experimental design. Int J Epidemiol. 2008, 37: 1430-1435.